PRESS RELEASE published on 10/05/2023 at 13:00, 2 years 8 months ago Theralase(R) Files US Patent for Enhanced Immunotherapy
PRESS RELEASE published on 09/29/2023 at 13:00, 2 years 9 months ago Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
PRESS RELEASE published on 09/27/2023 at 13:00, 2 years 9 months ago Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
PRESS RELEASE published on 09/21/2023 at 22:35, 2 years 9 months ago Theralase(R) Grants Stock Options
PRESS RELEASE published on 09/07/2023 at 10:30, 2 years 9 months ago Theralase(R) Closes Private Placement Equity Financing
PRESS RELEASE published on 08/29/2023 at 22:30, 2 years 10 months ago Theralase Release’s 2Q2023 Interim Financial Statements
PRESS RELEASE published on 06/30/2023 at 22:35, 2 years 11 months ago Theralase(R) Closes Non-Brokered Private Placement Equity Financing
PRESS RELEASE published on 06/06/2023 at 13:00, 3 years ago Theralase(R) Announces Appointment of New Independent Director
PRESS RELEASE published on 05/31/2023 at 03:30, 3 years ago Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
PRESS RELEASE published on 05/31/2023 at 01:35, 3 years ago Theralase(R) Releases 1Q2023 Interim Financial Statements
Published on 06/30/2026 at 00:05, 2 hours 43 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 3 hours 2 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 4 hours 47 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 11 hours 48 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 22:47, 4 hours ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 4 hours 42 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 4 hours 42 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 6 hours 17 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 6 hours 47 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 8 hours 18 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 8 hours 18 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 9 hours 3 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros